UniProt P01053
P01053
P01053 (UniProt P01053): 35 experimental structures and 1 predicted model on GenesisL1, 2 ligands bound. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- P01053
- Experimental structures
- 35
- Predicted models
- 1
- Ligands
- 2
Structures
36 records of P01053 in the MolNFT archive: 35 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1CIQ | Complex of two fragments of CI2, residues 1-40 and 41-64 | x-ray diffraction | A, B | — | — |
| 1CIQ | Complex of two fragments of CI2, residues 1-40 and 41-64 | x-ray diffraction | A, B | — | — |
| 1CIR | Complex of two fragments of CI2 [(1-40)(DOT)(41-64)] | solution nmr | A, B | — | — |
| 1CIR | Complex of two fragments of CI2 [(1-40)(DOT)(41-64)] | solution nmr | A, B | — | — |
| 1CIS | Context dependence of protein secondary structure formation. the three-dimensional structure and… | solution nmr | A | — | — |
| 1CIS | Context dependence of protein secondary structure formation. the three-dimensional structure and… | solution nmr | A | — | — |
| 1COA | The effect of cavity creating mutations in the hydrophobic core of chymotrypsin inhibitor 2 | x-ray diffraction | I | — | — |
| 1COA | The effect of cavity creating mutations in the hydrophobic core of chymotrypsin inhibitor 2 | x-ray diffraction | I | — | — |
| 1CQ4 | CI2 mutant with tetraglutamine (mgqqqqgm) replacing MET59 | x-ray diffraction | A, B | — | — |
| 1CQ4 | CI2 mutant with tetraglutamine (mgqqqqgm) replacing MET59 | x-ray diffraction | A, B | — | — |
| 1LW6 | Crystal Structure of the Complex of Subtilisin BPN' with Chymotrypsin Inhibitor 2 at 1.5 Angstrom… | x-ray diffraction | I | — | — |
| 1LW6 | Crystal structure of the complex of subtilisin bpn' with chymotrypsin inhibitor 2 at 1.5 ångström… | x-ray diffraction | I | — | — |
| 1YPA | Direct observation of better hydration at the N-terminus of an alpha-helix with glycine rather than… | x-ray diffraction | I | — | — |
| 1YPA | Direct observation of better hydration at the N-terminus of an alpha- helix with glycine rather… | x-ray diffraction | I | — | — |
| 1YPB | Direct observation of better hydration at the N-terminus of an alpha-helix with glycine rather than… | x-ray diffraction | I | — | — |
| 1YPB | Direct observation of better hydration at the N-terminus of an alpha- helix with glycine rather… | x-ray diffraction | I | — | — |
| 1YPC | Direct observation of better hydration at the N-terminus of an alpha-helix with glycine rather than… | x-ray diffraction | I | — | — |
| 1YPC | Direct observation of better hydration at the N-terminus of an alpha- helix with glycine rather… | x-ray diffraction | I | — | — |
| 2CI2 | Crystal and molecular structure of the serine proteinase inhibitor ci-2 from barley seeds | x-ray diffraction | I | — | — |
| 2CI2 | Crystal and molecular structure of the serine proteinase inhibitor ci- 2 from barley seeds | x-ray diffraction | I | — | — |
| 2SNI | Structural comparison of two serine proteinase-protein inhibitor complexes. eglin-C-subtilisin… | x-ray diffraction | I | — | — |
| 2SNI | Structural comparison of two serine proteinase-protein inhibitor complexes. eglin-C-subtilisin… | x-ray diffraction | I | — | — |
| 3CI2 | Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and… | solution nmr | A | — | — |
| 3CI2 | Refinement of the three-dimensional solution structure of barley serine proteinase inhibitor 2 and… | solution nmr | A | — | — |
| 5FBZ | Structure of subtilase SubHal from Bacillus halmapalus - complex with chymotrypsin inhibitor CI2A | x-ray diffraction | B, D | CA | — |
| 5FBZ | Structure of subtilase subhal from bacillus halmapalus - complex with chymotrypsin inhibitor CI2A | x-ray diffraction | B, D | — | — |
| 5FFN | Complex of subtilase SubTY from Bacillus sp. TY145 with chymotrypsin inhibitor CI2A | x-ray diffraction | I | — | — |
| 5FFN | Complex of subtilase subty from bacillus sp. TY145 with chymotrypsin inhibitor CI2A | x-ray diffraction | I | — | — |
| 6QIY | Ci-2, conformation 1 | x-ray diffraction | A | — | — |
| 6QIZ | Ci-2, conformation 2 | x-ray diffraction | A | — | — |
| 7A1H | Crystal structure of wild-type CI2 | x-ray diffraction | A | SO4 | — |
| 7A1H | Crystal structure of wild-type CI2 | x-ray diffraction | A | SO4 | — |
| 7A3M | Synergistic stabilization of a double mutant in CI2 from an in-cell library screen | x-ray diffraction | A | — | — |
| 7AOK | Crystal structure of CI2 mutant L49I | x-ray diffraction | A | SO4 | — |
| 7AON | Crystal structure of CI2 double mutant L49I,I57V | x-ray diffraction | A | SO4 | — |
| P01053 | AlphaFold monomer V2.0 prediction for subtilisin-chymotrypsin inhibitor-2A (P01053) | predicted | A | — | — |
Ligands
Experiment against prediction
- 5FBZ chain D against the predicted model P01053: TM-score 0.99, RMSD 0.37 Å
- 5FBZ chain D against the predicted model P01053: TM-score 0.99, RMSD 0.37 Å
- 1LW6 chain I against the predicted model P01053: TM-score 0.98, RMSD 0.42 Å
- 1LW6 chain I against the predicted model P01053: TM-score 0.98, RMSD 0.42 Å
- 1CQ4 chain A against the predicted model P01053: TM-score 0.97, RMSD 0.28 Å
- 1CQ4 chain A against the predicted model P01053: TM-score 0.97, RMSD 0.28 Å
- 1YPB chain I against the predicted model P01053: TM-score 0.97, RMSD 0.51 Å
- 1YPB chain I against the predicted model P01053: TM-score 0.97, RMSD 0.51 Å
- 1YPC chain I against the predicted model P01053: TM-score 0.97, RMSD 0.52 Å
- 1YPC chain I against the predicted model P01053: TM-score 0.97, RMSD 0.52 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.